XML 64 R49.htm IDEA: XBRL DOCUMENT v3.23.3
Segment and Geographic Information (Tables)
12 Months Ended
Sep. 30, 2023
Segment Reporting [Abstract]  
Schedule of financial information for business segments

The following is the summary of the financial information for the Company’s reportable segments for the fiscal years ended September 30, 2023, 2022 and 2021 (in thousands):

Year Ended September 30, 

2023

2022

2021

Revenue:

 

  

 

  

 

  

Life Sciences Products

$

305,184

$

199,230

$

199,606

Life Sciences Services

 

359,888

 

356,268

 

314,097

Total revenue

$

665,072

$

555,498

$

513,703

Operating income (loss):

 

 

Life Sciences Products

$

(30,321)

$

11,033

$

23,094

Life Sciences Services

 

(14,722)

 

10,784

 

22,659

Segment operating income (loss)

(45,043)

21,817

45,753

Amortization of intangible assets other than completed technology

28,207

24,965

29,299

Restructuring and restructuring related charges

4,577

712

13,749

Contingent consideration - fair value adjustments

(18,549)

600

Merger and acquisition costs and costs related to share repurchase(1)

13,842

17,329

20,662

Other unallocated corporate expenses

6

2,946

13,132

Total operating loss

(73,126)

(24,735)

(31,089)

Interest income

43,735

20,286

632

Interest expense

(4,589)

(2,037)

Loss on extinguishment of debt

(632)

Other, net

(1,042)

(266)

(16,475)

Loss before income taxes

$

(30,433)

$

(9,936)

$

(48,969)

(1) Includes expenses related to governance-related matters.

 

    

    

Assets:

September 30, 2023

September 30, 2022

Life Sciences Products

$

927,033

$

378,790

Life Sciences Services

794,752

849,603

Total assets

$

1,721,785

$

1,228,393

 

Schedule of reconciliation of reportable segment assets to corresponding consolidated amounts

Prior year amounts in the “Operating income (loss)” table above have been reclassified to conform to the current presentation.

The following is a reconciliation of the Company’s reportable segments’ assets to the amounts presented in the accompanying Consolidated Balance Sheets as of September 30, 2023 and 2022 (in thousands):

    

September 30, 

    

September 30, 

2023

2022

Segment assets

    

$

1,721,785

    

$

1,228,393

Cash and cash equivalents, restricted cash, and marketable securities

 

1,134,256

 

2,305,081

Deferred tax assets

 

571

 

1,169

Other assets

29,108

181,479

Total assets

$

2,885,720

$

3,716,122

Schedule of revenue from external customers attributed to geographic areas

Revenue from external customers is attributed to geographic areas based on locations in which customer orders are placed. Revenue by geographic area for the fiscal years ended September 30, 2023, 2022 and 2021 are as follows (in thousands):

Year Ended September 30, 

2023

    

2022

    

2021

Geographic Location:

North America

$

359,417

$

361,105

$

323,982

Africa

65,092

1,331

688

China

51,787

53,867

45,743

United Kingdom

26,764

30,258

31,539

Rest of Europe

109,856

79,005

77,266

Asia Pacific/ Other

 

52,156

 

29,932

 

34,485

Total revenue

$

665,072

$

555,498

$

513,703

Long-Lived Assets, Consisting of Property, Plant and Equipment by Geographic Area

Net property, plant and equipment by geographic area as of September 30, 2023 and 2022 is as follows (in thousands):

September 30, 

    

2023

    

2022

United States

$

78,533

$

84,809

China

53,146

56,585

Europe

70,654

11,610

Asia Pacific/ Other

 

3,411

 

1,466

Total property, plant, and equipment, net

$

205,744

$

154,470